Patents by Inventor Paul SCHOLL

Paul SCHOLL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20230265203
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: October 7, 2022
    Publication date: August 24, 2023
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Scott Ronald BRODEUR, Thomas B. FREEMAN, Gerald Henry Nabozny, Meera RAMANUJAM, Paul SCHOLL, Juergen STEFFGEN
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20200308271
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: December 21, 2019
    Publication date: October 1, 2020
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Mary Ruth Flack, Annette Bettina Galler, Bojan Lalovic, Kaori Maino, Steven John Padula, Paul Scholl, Koji Sha, Sudha Visvanathan
  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20190177420
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: July 18, 2018
    Publication date: June 13, 2019
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Scott Ronald Brodeur, Thomas B. Freeman, Gerald Henery Nabozny, Meera Ramanujam, Paul Scholl, Juergen Steffgen
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20170298126
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: April 13, 2017
    Publication date: October 19, 2017
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Mary Ruth FLACK, Annette Bettina GALLER, Bojan LALOVIC, Kaori MAINO, Steven John PADULA, Paul SCHOLL, Koji SHA, Sudha VISVANATHAN
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20170081402
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as Crohn's Disease, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: September 15, 2016
    Publication date: March 23, 2017
    Inventors: Wulf Otto BOECHER, Annette Bettina GALLER, Bojan LALOVIC, Steven John PADULA, Paul SCHOLL, Sudha VISVANATHAN
  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20170058038
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: August 31, 2016
    Publication date: March 2, 2017
    Inventors: Scott Ronald BRODEUR, Thomas B. FREEMAN, Gerald Henry NABOZNY, Meera RAMANUJAM, Paul SCHOLL, Juergen STEFFGEN